| scholarly article | Q13442814 |
| P2093 | author name string | Kyra Oswald-Richter | |
| Derya Unutmaz | |||
| David W Haas | |||
| Mindy Leelawong | |||
| Mark S Sundrud | |||
| Nikki Shariat | |||
| Stacy M Grill | |||
| P2860 | cites work | Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse | Q24290693 |
| JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome | Q24626901 | ||
| Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation | Q24676080 | ||
| Control of regulatory T cell development by the transcription factor Foxp3 | Q27860489 | ||
| Foxp3 programs the development and function of CD4+CD25+ regulatory T cells | Q27860714 | ||
| Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases | Q28131652 | ||
| B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes | Q28143530 | ||
| HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time | Q29547822 | ||
| Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection | Q29547852 | ||
| Viral dynamics in human immunodeficiency virus type 1 infection | Q29547908 | ||
| An essential role for Scurfin in CD4+CD25+ T regulatory cells | Q29618395 | ||
| X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy | Q29619109 | ||
| The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 | Q29619324 | ||
| CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production | Q29619536 | ||
| The scurfy mouse mutant has previously unrecognized hematological abnormalities and resembles Wiskott-Aldrich syndrome | Q33404650 | ||
| Regulatory T cells in autoimmmunity*. | Q33904108 | ||
| Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro | Q33942128 | ||
| Rhesus macaque dendritic cells efficiently transmit primate lentiviruses independently of DC-SIGN | Q34010226 | ||
| A history of prostate cancer treatment | Q34013878 | ||
| T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock | Q34052457 | ||
| CD25+CD4+ T cells contribute to the control of memory CD8+ T cells | Q34066063 | ||
| Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance | Q34111451 | ||
| CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor | Q34116317 | ||
| Cutting edge: depletion of CD4+CD25+ regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease | Q34132578 | ||
| Depletion of CD4+ T cells during immunization with nonviable Listeria monocytogenes causes enhanced CD8+ T cell-mediated protection against listeriosis. | Q51024747 | ||
| Genetic Reprogramming of Primary Human T Cells Reveals Functional Plasticity in Th Cell Differentiation | Q52005548 | ||
| Antigen-specific T cell suppression by human CD4+CD25+ regulatory T cells. | Q52011695 | ||
| T cell signaling mechanisms that regulate HIV-1 infection. | Q52018818 | ||
| Rapid turnover of T lymphocytes in SIV-infected rhesus macaques. | Q52247397 | ||
| CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. | Q54139898 | ||
| CD4+CD25high regulatory cells in human peripheral blood | Q56905059 | ||
| Twenty-first century Foxp3 | Q56987489 | ||
| CD4+ T-cell depletion in HIV infection: Are we closer to understanding the cause? | Q59375800 | ||
| IL-10 Is Required for Regulatory T Cells to Mediate Tolerance to Alloantigens In Vivo | Q60700622 | ||
| CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10 | Q73509865 | ||
| Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population | Q73740429 | ||
| Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry: allergics vs. non-allergics | Q74019442 | ||
| Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals | Q77704341 | ||
| The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality | Q78033315 | ||
| Regulatory T cells in spontaneous autoimmune encephalomyelitis | Q34448458 | ||
| IPEX is a unique X-linked syndrome characterized by immune dysfunction, polyendocrinopathy, enteropathy, and a variety of autoimmune phenomena | Q34468346 | ||
| Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. | Q34509694 | ||
| Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells. | Q34518941 | ||
| CD4+ CD25+ suppressor T cells: more questions than answers | Q34716304 | ||
| CD4(+) regulatory T cells in autoimmunity and allergy | Q34987296 | ||
| Identification and simian immunodeficiency virus infection of CD1d-restricted macaque natural killer T cells | Q35104944 | ||
| Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis | Q35159540 | ||
| Foxp3 and natural regulatory T cells: key to a cell lineage? | Q35204514 | ||
| CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes | Q35978587 | ||
| Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation | Q36367099 | ||
| Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes | Q36368207 | ||
| CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade | Q36369151 | ||
| CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection | Q36370230 | ||
| Distinct functional lineages of human V(alpha)24 natural killer T cells | Q36370354 | ||
| Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining | Q36370359 | ||
| Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation | Q36370863 | ||
| CD4+CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses | Q36371702 | ||
| Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy | Q36376383 | ||
| Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens | Q36954734 | ||
| Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding | Q39539552 | ||
| Memory and flexibility of cytokine gene expression as separable properties of human T(H)1 and T(H)2 lymphocytes | Q40687886 | ||
| Multifactorial nature of human immunodeficiency virus disease: implications for therapy | Q40777913 | ||
| Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. | Q40801370 | ||
| Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific | Q40910998 | ||
| Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines | Q41088030 | ||
| Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells | Q41908906 | ||
| Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood | Q41973912 | ||
| Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood | Q41988688 | ||
| Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state | Q42466421 | ||
| Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells | Q42947524 | ||
| Regulatory CD4+CD25+ T cells restrict memory CD8+ T cell responses | Q42947652 | ||
| Regulatory CD4 T cells control the size of the peripheral activated/memory CD4 T cell compartment | Q47243986 | ||
| Tracking the immunoregulatory mechanisms active during allograft tolerance | Q49022949 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | HIV | Q15787 |
| P304 | page(s) | E198 | |
| P577 | publication date | 2004-07-01 | |
| P1433 | published in | PLOS Biology | Q1771695 |
| P1476 | title | HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells | |
| P478 | volume | 2 |
| Q37525797 | A brief review of potential mechanisms of immune reconstitution inflammatory syndrome in HIV following antiretroviral therapy |
| Q34635742 | A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells |
| Q33815728 | A low T regulatory cell response may contribute to both viral control and generalized immune activation in HIV controllers |
| Q35862319 | A randomized case-control study of dynamic changes in peripheral blood Th17/Treg cell balance and interleukin-17 levels in highly active antiretroviral-treated HIV type 1/AIDS patients |
| Q37410702 | Adult AIDS-like disease in a novel inducible human immunodeficiency virus type 1 Nef transgenic mouse model: CD4+ T-cell activation is Nef dependent and can occur in the absence of lymphophenia |
| Q45362664 | Altered phenotype of regulatory T cells associated with lack of human immunodeficiency virus (HIV)-1-specific suppressive function. |
| Q56838012 | Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS |
| Q33709283 | Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS. |
| Q24533368 | Antimicrobial peptides from amphibian skin potently inhibit human immunodeficiency virus infection and transfer of virus from dendritic cells to T cells. |
| Q37300360 | CD25+ FoxP3+ Memory CD4 T Cells Are Frequent Targets of HIV Infection In Vivo |
| Q59359728 | CD4 T Cell Subsets and Pathways to HIV Latency |
| Q34633003 | CD4+ T cell depletion in human immunodeficiency virus (HIV) infection: role of apoptosis |
| Q35936484 | CD4+ Tregs and immune control |
| Q37515698 | CD4+CD25+ T regulatory cells activated during feline immunodeficiency virus infection convert T helper cells into functional suppressors through a membrane-bound TGFβ / GARP-mediated mechanism |
| Q37054806 | CD4+FOXP3+ Regulatory T-Cell Subsets in Human Immunodeficiency Virus Infection. |
| Q39295075 | CD4⁺ T cells from IPEX patients convert into functional and stable regulatory T cells by FOXP3 gene transfer |
| Q42254658 | Cellular interplay among Th17, Th1, and Treg cells in HIV-1 subtype "C" infection |
| Q90392454 | Changes in the Regulatory T-Lymphocyte Counts in HIV-Infected Patients with a Discordant Response to Antiretroviral Therapy |
| Q42945138 | Characterisation of Foxp3 splice variants in human CD4+ and CD8+ T cells—Identification of Foxp3Δ7 in human regulatory T cells |
| Q36938152 | Chemokine and cytokine mediated loss of regulatory T cells in lymph nodes during pathogenic simian immunodeficiency virus infection |
| Q34487847 | Comprehensive Analysis of Frequency and Phenotype of T Regulatory Cells in HIV Infection: CD39 Expression of FoxP3+T Regulatory Cells Correlates with Progressive Disease |
| Q90573569 | Constitutive Siglec-1 expression confers susceptibility to HIV-1 infection of human dendritic cell precursors |
| Q36752241 | Current concepts of HIV transmission |
| Q44033317 | Current concepts of HIV transmission |
| Q35208359 | Cytokine signals through PI-3 kinase pathway modulate Th17 cytokine production by CCR6+ human memory T cells |
| Q33238306 | Delayed functional maturation of natural regulatory T cells in the medulla of postnatal thymus: role of TSLP. |
| Q45373146 | Differential effect of CD4+Foxp3+ T-regulatory cells on the B and T helper cell responses to influenza virus vaccination |
| Q33940835 | Differentiation of IL-17-producing effector and regulatory human T cells from lineage-committed naive precursors |
| Q34944988 | Distinct expression profiles of TGF-beta1 signaling mediators in pathogenic SIVmac and non-pathogenic SIVagm infections |
| Q41880357 | Does CD4+CD25+foxp3+ cell (Treg) and IL-10 profile determine susceptibility to immune reconstitution inflammatory syndrome (IRIS) in HIV disease? |
| Q43920856 | Dying T cells trigger autoimmunity in HIV. |
| Q37706839 | Early and long-lasting alteration of effector CD45RA(-)Foxp3(high) regulatory T-cell homeostasis during HIV infection |
| Q35069126 | Early short-term antiretroviral therapy is associated with a reduced prevalence of CD8(+)FoxP3(+) T cells in simian immunodeficiency virus-infected controller rhesus macaques |
| Q82046500 | Elevated effector cell sensitivity to Treg-cell suppression that is not associated with reduced Th17-cell expression distinguishes HIV+ asymptomatic subjects from progressors |
| Q36486882 | Emerging possibilities in the development and function of regulatory T cells |
| Q36173997 | Endogenous TGF-beta activation by reactive oxygen species is key to Foxp3 induction in TCR-stimulated and HIV-1-infected human CD4+CD25- T cells |
| Q54942553 | Epigenetic Modulation of CD8⁺ T Cell Function in Lentivirus Infections: A Review. |
| Q37412137 | Epigenetic modification of FOXP3 in patients with chronic HIV infection. |
| Q56914829 | Expansion and productive HIV-1 infection of Foxp3 positive CD4 T cells at pleural sites of HIV/TB co-infection |
| Q33523291 | Expression and function of TNF and IL-1 receptors on human regulatory T cells |
| Q84376771 | Expression of GARP selectively identifies activated human FOXP3+ regulatory T cells |
| Q43515102 | FOXP3 expressing CD127lo CD4+ T cells inversely correlate with CD38+ CD8+ T cell activation levels in primary HIV-1 infection |
| Q33644550 | FOXP3 expression is upregulated in CD4T cells in progressive HIV-1 infection and is a marker of disease severity |
| Q36990794 | FOXP3 inhibits HIV-1 infection of CD4 T-cells via inhibition of LTR transcriptional activity |
| Q38671045 | Follicular Regulatory T Cells Are Highly Permissive to R5-Tropic HIV-1. |
| Q81083994 | Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells |
| Q41648040 | Forkhead box protein 3(+) regulatory T cells and Helios(+) subset in perinatally acquired HIV. |
| Q42655696 | Forkhead-Box-P3 Gene Transfer in Human CD4+ T Conventional Cells for the Generation of Stable and Efficient Regulatory T Cells, Suitable for Immune Modulatory Therapy |
| Q35566145 | FoxP3 enhances HIV-1 gene expression by modulating NFkappaB occupancy at the long terminal repeat in human T cells |
| Q36315222 | FoxP3+ CD25+ CD8+ T-cell induction during primary simian immunodeficiency virus infection in cynomolgus macaques correlates with low CD4+ T-cell activation and high viral load |
| Q36915916 | FoxP3+CD4+ regulatory T cells play an important role in acute HIV-1 infection in humanized Rag2-/-gammaC-/- mice in vivo |
| Q38572329 | Foxp3 and Treg cells in HIV-1 infection and immuno-pathogenesis |
| Q36794299 | Foxp3 in control of the regulatory T cell lineage |
| Q38989129 | Foxp3 inhibits HDAC1 activity to modulate gene expression in human T cells |
| Q28741958 | Frequency of circulating regulatory T cells increases during chronic HIV infection and is largely controlled by highly active antiretroviral therapy |
| Q26744626 | Functional Mechanisms of Treg in the Context of HIV Infection and the Janus Face of Immune Suppression |
| Q34574856 | Functional characterization of HLA-G⁺ regulatory T cells in HIV-1 infection |
| Q36842852 | GARP-TGF-β complexes negatively regulate regulatory T cell development and maintenance of peripheral CD4+ T cells in vivo |
| Q35646681 | Gene/cell therapy approaches for Immune Dysregulation Polyendocrinopathy Enteropathy X-linked syndrome. |
| Q21146758 | Generalized immune activation as a direct result of activated CD4+ T cell killing |
| Q40055892 | Generation of potent and stable human CD4+ T regulatory cells by activation-independent expression of FOXP3. |
| Q24613773 | Glucocorticoid-induced tumor necrosis factor receptor family-related protein triggering enhances HIV-specific CD4+ T cell cytokine secretion and protects HIV-specific CD4+ T cells from apoptosis |
| Q39610377 | Gut mucosal FOXP3+ regulatory CD4+ T cells and Nonregulatory CD4+ T cells are differentially affected by simian immunodeficiency virus infection in rhesus macaques |
| Q37341025 | HIV induced AIDS and related cancers: chronic immune activation and future therapeutic strategies |
| Q35067233 | HIV-1 Vpr accelerates viral replication during acute infection by exploitation of proliferating CD4+ T cells in vivo |
| Q37104632 | HIV-1 binding to CD4 on CD4+CD25+ regulatory T cells enhances their suppressive function and induces them to home to, and accumulate in, peripheral and mucosal lymphoid tissues: an additional mechanism of immunosuppression |
| Q35848896 | HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS. |
| Q39321727 | Helicobacter pylori VacA toxin inhibits human immunodeficiency virus infection of primary human T cells |
| Q35131194 | Helminths and HIV infection: epidemiological observations on immunological hypotheses |
| Q36871006 | Highly active antiretroviral therapy reduces pulmonary IL-8 in HIV-positive women smokers |
| Q37223366 | Homing in on acute graft vs. host disease: tissue-specific T regulatory and Th17 cells |
| Q35317078 | Host immune responses that promote initial HIV spread |
| Q37405703 | Human T cells express CD25 and Foxp3 upon activation and exhibit effector/memory phenotypes without any regulatory/suppressor function |
| Q39489626 | Human immunodeficiency virus type 1 Nef in human monocyte-like cell line THP-1 expands treg cells via toll-like receptor 2. |
| Q37452486 | Human regulatory T cells are targets for human immunodeficiency Virus (HIV) infection, and their susceptibility differs depending on the HIV type 1 strain |
| Q35951526 | IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage |
| Q33283061 | Identification of a CCR5-expressing T cell subset that is resistant to R5-tropic HIV infection |
| Q28593882 | Identification of a regulatory T cell specific cell surface molecule that mediates suppressive signals and induces Foxp3 expression |
| Q36395703 | Imbalance of regulatory T cells in human autoimmune diseases |
| Q37400623 | Immune activation driven by CTLA-4 blockade augments viral replication at mucosal sites in simian immunodeficiency virus infection. |
| Q40377124 | Immune deficiency in HIV-1 infection: novel therapeutic approaches targeting innate and adaptive responses |
| Q34984010 | Immune exhaustion occurs concomitantly with immune activation and decrease in regulatory T cells in viremic chronically HIV-1-infected patients |
| Q37993738 | Immune modulation of inflammatory conditions: regulatory T cells for treatment of GvHD. |
| Q37418185 | Immune quiescence: a model of protection against HIV infection |
| Q44479361 | Immune reconstitution inflammatory syndrome (IRIS) |
| Q37058004 | Immune reconstitution inflammatory syndrome in HIV-infected patients receiving antiretroviral therapy : pathogenesis, clinical manifestations and management |
| Q36342114 | Immune reconstitution inflammatory syndrome: more answers, more questions |
| Q27687272 | Immune restoration after antiretroviral therapy: the pitfalls of hasty or incomplete repairs. |
| Q64237765 | Immune signatures for HIV-1 and HIV-2 induced CD4T cell dysregulation in an Indian cohort |
| Q34608946 | Immunopathogenesis of asymptomatic chronic HIV Infection: the calm before the storm |
| Q35626699 | Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART |
| Q33889113 | In vivo depletion of CD4(+)CD25(hi) regulatory T cells is associated with improved antiviral responses in cats chronically infected with feline immunodeficiency virus |
| Q33840429 | In vivo expansion of CD4CD45RO-CD25 T cells expressing foxP3 in IL-2-treated HIV-infected patients |
| Q27021524 | Incomplete immune recovery in HIV infection: mechanisms, relevance for clinical care, and possible solutions |
| Q35363011 | Increased frequency of regulatory T cells accompanies increased immune activation in rectal mucosae of HIV-positive noncontrollers |
| Q54296583 | Increased proportions of B cells with spontaneous production of interleukin-10 in HIV-infected individuals are normalized during combination antiretroviral therapy: a longitudinal study. |
| Q28748867 | Increased sensitivity of CD4+ T-effector cells to CD4+CD25+ Treg suppression compensates for reduced Treg number in asymptomatic HIV-1 infection |
| Q36059631 | Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype |
| Q36228356 | Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens |
| Q34571341 | Infection of CD127+ (interleukin-7 receptor+) CD4+ cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infection |
| Q37123309 | Infection with feline immunodeficiency virus directly activates CD4+ CD25+ T regulatory cells |
| Q28079717 | Innate and Adaptive Immune Regulation During Chronic Viral Infections |
| Q27488287 | Level, phenotype and activation status of CD4+FoxP3+regulatory T cells in patients chronically infected with human immunodeficiency virus and/or hepatitis C virus |
| Q45365445 | Loss of balance between T helper type 17 and regulatory T cells in chronic human immunodeficiency virus infection |
| Q34247040 | Modeling adaptive regulatory T-cell dynamics during early HIV infection. |
| Q38263002 | Modulation of Regulatory T-Cell Subsets in Very Long-Term Treated Aviremic HIV(+) Patients and Untreated Viremic Patients. |
| Q35897923 | Nanotechnology as a New Therapeutic Approach to Prevent the HIV-Infection of Treg Cells |
| Q36423940 | Natural regulatory T cells and persistent viral infection |
| Q37299722 | Naturally occurring and inducible T-regulatory cells modulating immune response in allergic asthma |
| Q37141166 | Neuromodulatory activities of CD4+CD25+ regulatory T cells in a murine model of HIV-1-associated neurodegeneration |
| Q33833910 | Partial regulatory T cell depletion prior to acute feline immunodeficiency virus infection does not alter disease pathogenesis |
| Q46266432 | Peripheral CD4 loss of regulatory T cells is associated with persistent viraemia in chronic HIV infection |
| Q34600441 | Poor immune reconstitution in HIV-infected patients associates with high percentage of regulatory CD4+ T cells |
| Q36073821 | Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. |
| Q36845770 | Preservation of FoxP3+ regulatory T cells in the peripheral blood of human immunodeficiency virus type 1-infected elite suppressors correlates with low CD4+ T-cell activation. |
| Q34598553 | Probing the effector and suppressive functions of human T cell subsets using antigen-specific engineered T cell receptors |
| Q41848701 | Proliferation and foxp3 expression in virus-specific memory CD8+ T lymphocytes |
| Q44816481 | Proliferation of weakly suppressive regulatory CD4+ T cells is associated with over-active CD4+ T-cell responses in HIV-positive patients with mycobacterial immune restoration disease. |
| Q37460580 | Protective versus pathogenic anti-CD4 immunity: insights from the study of natural resistance to HIV infection |
| Q59127693 | Rationale for an Association Between PD1 Checkpoint Inhibition and Therapeutic Vaccination Against HIV |
| Q34430345 | Reduced cellular susceptibility to in vitro HIV infection is associated with CD4+ T cell quiescence |
| Q36148406 | Regulation of immunity by self-reactive T cells |
| Q52715799 | Regulatory T Cells As Potential Targets for HIV Cure Research. |
| Q47608472 | Regulatory T Cells Contribute to HIV-1 Reservoir Persistence in CD4+ T Cells Through Cyclic Adenosine Monophosphate-Dependent Mechanisms in Humanized Mice In Vivo |
| Q42667085 | Regulatory T cell expansion and immune activation during untreated HIV type 1 infection are associated with disease progression |
| Q44442856 | Regulatory T cells and chronic immune activation in human immunodeficiency virus 1 (HIV-1)-infected children |
| Q37101255 | Regulatory T cells and human disease |
| Q37550813 | Regulatory T cells dampen pulmonary inflammation and lung injury in an animal model of pneumocystis pneumonia |
| Q81355901 | Regulatory T cells in HIV infection: who's suppressing what? |
| Q37139998 | Regulatory T cells in HIV infection: who's suppressing what? |
| Q45390515 | Regulatory T cells in human immunodeficiency virus-infected patients are elevated and independent of immunological and virological status, as well as initiation of highly active anti-retroviral therapy |
| Q82076756 | Regulatory T cells in rheumatoid arthritis |
| Q36563550 | Regulatory T cells in virus infections |
| Q95363128 | Regulatory T cells: the ultimate HIV reservoir? |
| Q59564528 | Regulatory T-cell function: When suppressor cells can't suppress |
| Q43513695 | Regulatory T-cell therapy: is it ready for the clinic? |
| Q27022973 | Regulatory T-cells: diverse phenotypes integral to immune homeostasis and suppression |
| Q33373073 | Resting regulatory CD4 T cells: a site of HIV persistence in patients on long-term effective antiretroviral therapy |
| Q36864267 | Reversal of global CD4+ subset dysfunction is associated with spontaneous clinical resolution of pulmonary sarcoidosis |
| Q35131530 | Revisiting immune exhaustion during HIV infection |
| Q64374924 | Salivary gland immunization Wharton's duct activates differential T-cell responses within the salivary gland immune system |
| Q34295695 | Selective impact of HIV disease progression on the innate immune system in the human female reproductive tract |
| Q36315704 | Severe depletion of CD4+ CD25+ regulatory T cells from the intestinal lamina propria but not peripheral blood or lymph nodes during acute simian immunodeficiency virus infection |
| Q90479471 | Single-Cell Technologies Applied to HIV-1 Research: Reaching Maturity |
| Q34597933 | Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development |
| Q64097650 | Single-cell characterization and quantification of translation-competent viral reservoirs in treated and untreated HIV infection |
| Q93010915 | Specific Activation In Vivo of HIV-1 by a Bromodomain Inhibitor from Monocytic Cells in Humanized Mice under Antiretroviral Therapy |
| Q28469094 | Strong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removal |
| Q36415780 | Studies of HIV-associated immune responses in lymphoid compartments |
| Q35652583 | Suppression of HIV-specific T cell activity by lymph node CD25+ regulatory T cells from HIV-infected individuals |
| Q33359540 | Suppression of HIV-specific and allogeneic T cell activation by human regulatory T cells is dependent on the strength of signals |
| Q38984682 | Susceptibility of human Th17 cells to human immunodeficiency virus and their perturbation during infection. |
| Q38179375 | T Cell Transcription Factors and Their Impact on HIV Expression |
| Q34510458 | T cell activation but not polyfunctionality after primary HIV infection predicts control of viral load and length of the time without therapy. |
| Q35459820 | T regulatory cells: aid or hindrance in the clearance of disease? |
| Q37018222 | T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies. |
| Q37068196 | The biology of FoxP3: a key player in immune suppression during infections, autoimmune diseases and cancer. |
| Q82644038 | The decrease of regulatory T cells correlates with excessive activation and apoptosis of CD8+ T cells in HIV-1-infected typical progressors, but not in long-term non-progressors |
| Q35074334 | The metalloprotease ADAM12 regulates the effector function of human Th17 cells |
| Q41998069 | The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs. |
| Q36242461 | The role of CD4+CD25+ regulatory T cells in viral infections |
| Q40106774 | The role of nanotechnology in the treatment of viral infections. |
| Q36535760 | The role of virus-induced regulatory T cells in immunopathology |
| Q35847636 | Transcription factor GATA-1 potently represses the expression of the HIV-1 coreceptor CCR5 in human T cells and dendritic cells |
| Q83350829 | UBD, a downstream element of FOXP3, allows the identification of LGALS3, a new marker of human regulatory T cells |
Search more.